Candel Therapeutics, Inc. (CADL) insider trading.
In Q3 2026, insiders at Candel Therapeutics, Inc. reported 6 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $3.6M.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -317,692
- Insiders
- 3
- Last filed
- 2026-09-11
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Tak Paul Peter | Director, Officer · Chief Executive Officer | 3 | 0 | 2 |
| Tyagarajan Seshu | Officer · Chief Technology Officer | 2 | 0 | 2 |
| Barone Francesca | Officer · Chief Scientific Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Tak Paul Peter | S (D) | 59,379 | $10.46 | 113,321 | Form 4 |
| 2026-09-10 | Tak Paul Peter | M (A) | 125,000 | $1.55 | 393,566 | Form 4 |
| 2026-09-10 | Tak Paul Peter | S (D) | 220,866 | $11.5 | 172,700 | Form 4 |
| 2026-08-17 | Tyagarajan Seshu | S (D) | 7,000 | $12 | 76,865 | Form 4 |
| 2026-06-29 | Barone Francesca | S (D) | 23,447 | $10.06 | 77,362 | Form 4 |
| 2026-06-29 | Tyagarajan Seshu | S (D) | 7,000 | $10.02 | 83,865 | Form 4 |
Transaction codes in this quarter
Get CADL insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1841387&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CADL company page · Candel Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Candel Therapeutics, Inc. (CADL)?
In Q3 2026, insiders at Candel Therapeutics, Inc. reported 6 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $3.6M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Candel Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cadl.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.